Cymabay Therapeutics Inc (NASDAQ:CBAY)
| 3.33 Delayed Data As of Jul 14 |  +0.01 / +0.30%Today’s Change | 1.21 Today|||52-Week Range 6.69 | +69.90% Year-to-Date |
Latest CBAY News | Press Releases
No recent news for Cymabay Therapeutics Inc.
Today’s Trading
| Previous close | 3.32 |
| Today’s open | 3.32 |
| Day’s range | 3.30 - 3.41 |
| Volume | 1,153,377 |
| Average volume (3 months) | 2,843,849 |
| Market cap | $239.0M |
Data as of 4:44pm ET, 07/14/2020
Growth & Valuation
| Earnings growth (last year) | -22.21% |
| Earnings growth (this year) | +39.53% |
| Earnings growth (next 5 years) | -- |
| Revenue growth (last year) | -- |
| P/E ratio | NM |
| Price/Sales | -- |
| Price/Book | 1.28 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| DITAMCON Distributing C... | +1.94 | +3.46% |
| AXMPAaron Sparks Industr... | 0.00 | 0.00% |
| --Pixarbio Corp | 0.00 | 0.00% |
| NUSNU Skin Enterprises ... | +0.02 | +0.04% |
Data as of 4:00pm ET, 07/14/2020
Financials
| Next reporting date | August 6, 2020 |
| EPS forecast (this quarter) | -$0.25 |
| Annual revenue (last year) | $0.00 |
| Annual profit (last year) | -$102.8M |
| Net profit margin | -- |
Profile
Sector Health Technology |
Industry Biotechnology |
No executives to display |
Corporate headquarters Newark, California |
Forecasts
